Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Brain Pathology (Zurich, Switzerland)|August 25, 2010
Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activityDavid X Medina, Antonella Caccamo, Salvatore OddoThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 18, 2013
Glucocorticoids exacerbate cognitive deficits in TDP-25 transgenic mice via a glutathione-mediated mechanism: implications for aging, stress and TDP-43 proteinopathiesAntonella Caccamo, David X Medina, Salvatore OddoMovement Disorders : Official Journal of the Movement Disorder Society|May 17, 2022
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Simone Engelender, Leonidas Stefanis, Salvatore Oddo, et al.Nature Reviews. Neuroscience|June 7, 2007
Intracellular amyloid-beta in Alzheimer's diseaseFrank M LaFerla, Kim N Green, Salvatore OddoPlos One|October 8, 2011
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficitsSmita Majumder, Arlan Richardson, Randy Strong, et al.Neurobiology of Aging|August 20, 2013
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic miceDavid X Medina, Miranda E Orr, Salvatore OddoInternational Journal of Molecular Sciences|July 12, 2025
The Role of S6K1 in Aging and Alzheimer's Disease: Mechanistic Insights and Therapeutic PotentialSalvatore Oddo, Marika Lanza, Giovanna Casili, et al.Human Molecular Genetics|March 15, 2014
Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathiesElena V Wisely, Yang K Xiang, Salvatore OddoMolecular Neurodegeneration|July 15, 2016
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's diseaseRamon Velazquez, Darren M Shaw, Antonella Caccamo, et al.Experimental Gerontology|December 8, 2014
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin storyArlan Richardson, Veronica Galvan, Ai-Ling Lin, et al.Pageof 11